Definium Therapeutics, Inc. · NASDAQ:DFTX

Sullivan Mark received 62,500 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Jun 22, 2026 · Filed Jun 22, 2026

On Jun 22, 2026, Sullivan Mark (Chief Legal Officer) received 62,500 Definium Therapeutics, Inc. shares as an award, leaving 333,579 shares. Filed Jun 22, 2026 (Form 4).

Awarded
62,500 shares
Holding after
333,579 shares
Trading plan
No
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common SharesAward62,500333,579Direct

Source

View original at SEC

Related